N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells

被引:4
作者
Lai, Jie [1 ,2 ]
Zhou, Zhiyong [1 ]
Hu, Kan [2 ]
Yu, Honglong [1 ]
Su, Xingyao [1 ]
Niu, Xiaoqiang [1 ]
Li, Huizi [1 ]
Mao, Shengxun [1 ]
机构
[1] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China
[2] Pingxiang Peoples Hosp, Dept Gen Surg, Pingxiang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
M6A methylation; MeRIP-seq; colorectal cancer; drug-resistance; OVARIAN-CANCER; RESISTANCE; EXPRESSION; N-6-METHYLADENOSINE; OVEREXPRESSION; INHIBITOR; FOS;
D O I
10.1080/15592294.2023.2298058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the most common and abundant modification in mammalian mRNAs and non-coding RNAs. Increasing evidence shows that the alteration of m6A modification level could regulate tumour proliferation, metastasis, self-renewal, and immune infiltration by regulating the related expression of tumour genes. However, the role of m6A modification in colorectal cancer (CRC) drug resistance is unclear. Here, MeRIP-seq and RNA-seq techniques were utilized to obtain mRNA, lncRNA expression, and their methylation profiles in 5-Fluorouracil (5-FU)-resistant colon cancer HCT-15 cells and control cells. In addition, we performed detailed bioinformatics analysis as well as in vitro experiments of lncRNA to explore the function of lncRNA with differential m6A in CRC progression and drug resistance. In this study, we obtained the m6A methylomic landscape of CRC cells and resistance group cells by MeRIP-seq and RNA-seq. We identified 3698 differential m6A peaks, of which 2224 were hypermethylated, and 1474 were hypomethylated. Among the lncRNAs, 60 were hypermethylated, and 38 were hypomethylated. GO and KEGG analysis annotations showed significant enrichment of endocytosis and MAPK signalling pathways. Moreover, knockdown of lncRNA ADIRF-AS1 and AL139035.1 promoted CRC proliferation and invasive metastasis in vitro. lncRNA- mRNA network showed that ADIRF-AS1 and AL139035.1 May play a key role in regulating drug resistance formation. We provide the first m6A methylation profile in 5-FU resistance CRC cells and analyse the functions of differential m6A-modified mRNAs and lncRNAs. Our results indicated that differential m6A RNAs were significantly associated with MAPK signalling and endocytosis after induction of 5-FU resistance. Knockdown of LncRNA ADIRF-AS1 and AL139035.1 promotes CRC progression and might be critical in regulating drug resistance formation. We outline the first m6A methylation profile of mRNA and lncRNA in CRC cells involved in 5-FU resistance.This study sought to identify the critical genes that produced 5-FU resistance by analysing the functions of differentially m6A-modified mRNAs and lncRNAs.
引用
收藏
页数:22
相关论文
共 58 条
  • [1] Investigating the effect of radiosensitizer for Ursolic Acid and Kamolonol Acetate on HCT-116 cell line
    Abdali, Maede Hasan
    Afshar, Saeid
    Pashaki, Abdolazim Sedighi
    Dastan, Dara
    Gholami, Mohammad Hadi
    Mahmoudi, Roghayeh
    Saidijam, Massoud
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (01)
  • [2] Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
    Afshar, Saeid
    Pashaki, Abdolazim Sedighi
    Najafi, Rezvan
    Nikzad, Safoora
    Amini, Razieh
    Shabab, Nooshin
    Khiabanchian, Omid
    Tanzadehpanah, Hamid
    Saidijam, Massoud
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2020, 45 (01) : 50 - 58
  • [3] Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
    Azwar, Shamin
    Seow, Heng Fong
    Abdullah, Maha
    Jabar, Mohd Faisal
    Mohtarrudin, Norhafizah
    [J]. BIOLOGY-BASEL, 2021, 10 (09):
  • [4] Signaling from Axon Guidance Receptors
    Bashaw, Greg J.
    Klein, Ruediger
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (05): : a001941
  • [5] Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation
    Bhosale, Pritam Bhagwan
    Kim, Hun Hwan
    Abusaliya, Abuyaseer
    Vetrivel, Preethi
    Ha, Sang Eun
    Park, Min Yeong
    Lee, Ho Jeong
    Kim, Gon Sup
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [6] 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
    Blondy, Sabrina
    David, Valentin
    Verdier, Mireille
    Mathonnet, Muriel
    Perraud, Aurelie
    Christou, Niki
    [J]. CANCER SCIENCE, 2020, 111 (09) : 3142 - 3154
  • [7] m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance
    Chen, Chen
    Guo, Yuying
    Guo, Yaxin
    Wu, Xiaoke
    Si, Chaohua
    Xu, Yanxin
    Kang, Qiaozhen
    Sun, Zhenqiang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] fastp: an ultra-fast all-in-one FASTQ preprocessor
    Chen, Shifu
    Zhou, Yanqing
    Chen, Yaru
    Gu, Jia
    [J]. BIOINFORMATICS, 2018, 34 (17) : 884 - 890
  • [9] Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6A methylation promotes disease progression and sorafenib resistance
    Chen, Yi-tian
    Xiang, Dan
    Zhao, Xiao-yue
    Chu, Xiao-yuan
    [J]. HUMAN CELL, 2021, 34 (06) : 1800 - 1811
  • [10] Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
    Crea, Francesco
    Nobili, Stefania
    Paolicchi, Elisa
    Perrone, Gabriele
    Napoli, Cristina
    Landini, Ida
    Danesi, Romano
    Mini, Enrico
    [J]. DRUG RESISTANCE UPDATES, 2011, 14 (06) : 280 - 296